Log In
Print this Print this

PrevOnco, lansoprazole

  Manage Alerts
Collapse Summary General Information
Company Innovus Pharmaceuticals Inc.
DescriptionLansoprazole formulated with NexMed's NexACT delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II/III
Standard IndicationLiver cancer
Indication DetailsTreat hepatocellular carcinoma (HCC)
Regulatory Designation
PartnerApricus Biosciences Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today